There is no cure for alcoholism, which is now clinically called alcohol use disorder (AUD). It is classified as a chronic brain disorder, meaning it can be treated and managed effectively, but not eliminated the way you’d cure an infection with antibiotics. Heavy drinking causes lasting changes in the brain that persist even after someone stops drinking, and those changes keep a person vulnerable to relapse long after their last drink.
That said, “no cure” does not mean “no hope.” Many people with AUD achieve long-term remission, rebuild their lives, and never return to problematic drinking. The distinction matters: a cure would mean the disease is gone for good, while remission means the disease is under control. Understanding the difference helps explain why treatment works but also why ongoing effort is part of the picture.
Why Alcoholism Is Considered a Chronic Condition
Repeated heavy drinking reshapes the brain in ways that outlast the drinking itself. Over time, the brain shifts control over drinking behavior from the prefrontal cortex, which handles conscious decision-making, to the basal ganglia, which manages automatic habits. Drinking becomes less of a choice and more of a deeply grooved reflex. At the same time, alcohol disrupts the brain’s circuits for motivation, impulse control, memory, and sleep regulation.
One of the most significant changes involves the brain’s stress and emotion center. Alcohol temporarily dampens negative emotions like anxiety and irritability. But when someone stops drinking, that same emotional circuitry becomes hyperactive, flooding them with heightened anxiety, restlessness, and emotional pain. This rebound effect is a major reason early sobriety feels so difficult and why cravings can be intense even months into recovery. These aren’t signs of weakness; they’re the brain recalibrating after being chemically altered.
The damage is especially pronounced for people who started drinking heavily as teenagers. Adolescent drinking can accelerate the loss of gray matter in the brain’s frontal cortex and slow the development of white matter, disrupting brain development during a critical window.
What Happens During Withdrawal
For people who have been drinking heavily for a long time, stopping suddenly can be medically dangerous. Alcohol withdrawal is one of the few substance withdrawal syndromes that can be life-threatening, which is why medical supervision is often necessary.
Withdrawal follows a fairly predictable timeline. Minor symptoms like insomnia, tremors, anxiety, nausea, and headache typically begin 6 to 12 hours after the last drink. Hallucinations can appear at 12 to 24 hours. Seizures are most likely between 24 and 48 hours. The most severe form, delirium tremens, involving disorientation, visual hallucinations, fever, and dangerous spikes in heart rate and blood pressure, peaks at 48 to 72 hours.
Not everyone experiences the severe end of this spectrum. People with a history of withdrawal seizures, previous episodes of delirium tremens, very high recent drinking levels, or other medical or psychiatric conditions are at the highest risk and are typically recommended for inpatient detox. A safe detox is the first step, not the treatment itself.
Medications That Help
Three medications are currently approved for treating AUD, and they work in different ways. None of them is a cure, but they can meaningfully reduce cravings or drinking.
- Naltrexone blocks the brain’s opioid receptors, which are responsible for the pleasurable buzz alcohol produces. By dulling that reward, it reduces both cravings and the reinforcing effects of drinking. In a review of 53 trials with over 9,000 participants, naltrexone decreased heavy drinking (with roughly 1 in 12 people benefiting beyond what a placebo would provide) and modestly increased abstinence rates.
- Acamprosate helps stabilize brain chemistry that gets thrown off by prolonged drinking, particularly the brain’s excitatory signaling system. A review of 24 trials found it reduced return to drinking, with about 1 in 9 people benefiting beyond placebo.
- Disulfiram takes a completely different approach. It doesn’t reduce cravings at all. Instead, it causes unpleasant reactions (flushing, nausea, vomiting) if you drink while taking it, creating a strong deterrent. The evidence for its effectiveness is weaker than for the other two, and it relies heavily on the person being motivated enough to keep taking it daily.
These medications work best when combined with therapy rather than used alone.
Therapy and Behavioral Approaches
Several types of therapy have strong track records for AUD. Cognitive behavioral therapy helps people identify the thought patterns and situations that trigger drinking, then build practical coping strategies. Motivational enhancement therapy focuses on strengthening a person’s own desire and confidence to change, which can be especially effective for people who are ambivalent about quitting. Twelve-step facilitation helps connect people with peer support networks like Alcoholics Anonymous.
Research comparing these three approaches head-to-head has found them broadly similar in effectiveness, with some evidence that motivational enhancement therapy produces slightly better outcomes in terms of reduced drinking intensity at follow-ups of 7 to 12 months after treatment. The “best” therapy is often the one that resonates with a particular person and that they’ll stick with. Many treatment programs combine elements of all three.
Relapse Is Common, Not a Failure
Relapse rates for alcohol are high. Some studies put the figure as high as 80 percent during the first year after treatment. That number can feel discouraging, but it’s comparable to relapse rates for other chronic conditions like diabetes and hypertension, where people also struggle to maintain lifestyle changes over time. A relapse doesn’t erase the progress someone has made; it signals a need to adjust the treatment plan.
The warning signs tend to follow a pattern: shifting priorities away from recovery, withdrawing from support networks, increasing restlessness and irritability, and a general sense of discontent. Recognizing these behavioral shifts early, before they lead to a drink, is one of the most practical skills people learn in therapy. The first year is the highest-risk period, and building a strong routine of support during that window matters enormously.
New Treatments on the Horizon
Two areas of research are generating significant attention. A study published by NYU Langone found that two doses of psilocybin, the active compound in psychedelic mushrooms, combined with psychotherapy, reduced heavy drinking by 83 percent on average over eight months. Nearly half of the psilocybin group (48 percent) stopped drinking entirely, compared with 24 percent in the placebo group. This is still experimental and not available as a standard treatment, but the results were striking enough to prompt larger trials.
Separately, semaglutide, the compound behind widely used weight-loss medications, has completed a Phase 2 clinical trial for AUD. Early animal studies and anecdotal reports had suggested that GLP-1 drugs might reduce alcohol cravings, and the formal trial results were published in JAMA Psychiatry in early 2025. Larger trials will be needed to determine whether it becomes an approved option.
What Long-Term Recovery Looks Like
Recovery from AUD is not a single event. It’s an ongoing process of managing a condition that, by its nature, leaves the brain primed to return to old patterns under the right circumstances. For many people, this means some combination of continued therapy, medication, peer support, and deliberate lifestyle changes around stress, sleep, and social environments.
The brain does heal over time. Many of the cognitive deficits caused by heavy drinking, including problems with memory, attention, and decision-making, improve significantly with sustained abstinence. The longer someone maintains recovery, the more their brain chemistry stabilizes and the less effort it takes to resist cravings. People who were once unable to function without alcohol go on to live full, stable lives. The condition isn’t curable, but for many people, it becomes manageable enough that it no longer defines their daily experience.